SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-21-237921
Filing Date
2021-08-05
Accepted
2021-08-05 17:16:48
Documents
10

Document Format Files

Seq Description Document Type Size
1 S-3 d349600ds3.htm S-3 424747
2 EX-4.2 d349600dex42.htm EX-4.2 301077
3 EX-4.3 d349600dex43.htm EX-4.3 299744
4 EX-5.1 d349600dex51.htm EX-5.1 13953
5 EX-5.2 d349600dex52.htm EX-5.2 6927
6 EX-23.1 d349600dex231.htm EX-23.1 1471
7 GRAPHIC g349600g33p38.jpg GRAPHIC 85897
8 GRAPHIC g349600g40y52.jpg GRAPHIC 33203
9 GRAPHIC g349600g51z77.jpg GRAPHIC 50687
10 GRAPHIC g349600g95m44.jpg GRAPHIC 51190
  Complete submission text file 0001193125-21-237921.txt   1332903
Mailing Address 50 HAMPSHIRE STREET, 8TH FLOOR CAMBRIDGE MA 02139
Business Address 50 HAMPSHIRE STREET, 8TH FLOOR CAMBRIDGE MA 02139 617-714-4096
Surface Oncology, Inc. (Filer) CIK: 0001718108 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-258518 | Film No.: 211149504
SIC: 2836 Biological Products, (No Diagnostic Substances)